76 related articles for article (PubMed ID: 15781633)
1. Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression.
Cronwright G; Le Blanc K; Götherström C; Darcy P; Ehnman M; Brodin B
Cancer Res; 2005 Mar; 65(6):2207-15. PubMed ID: 15781633
[TBL] [Abstract][Full Text] [Related]
2. Quantification of SSX mRNA expression in human bone and soft tissue tumors using nucleic acid sequence-based amplification.
Naka N; Joyama S; Tsukamoto Y; Yoshioka K; Hashimoto N; Ujiiye T; Hayashi T; Kawase M; Mano M; Ishiguro S; Myoui A; Ueda T; Yoshikawa H; Araki N; Itoh K
J Mol Diagn; 2005 May; 7(2):187-97. PubMed ID: 15858142
[TBL] [Abstract][Full Text] [Related]
3. Establishing and Validating an Aging-Related Prognostic Signature in Osteosarcoma.
Ma Y; Zheng S; Xu M; Chen C; He H
Stem Cells Int; 2023; 2023():6245160. PubMed ID: 37964984
[TBL] [Abstract][Full Text] [Related]
4. Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review).
Ren S; Zhang Z; Li M; Wang D; Guo R; Fang X; Chen F
Int J Oncol; 2023 Jun; 62(6):. PubMed ID: 37144487
[TBL] [Abstract][Full Text] [Related]
5. Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer.
Nin DS; Deng LW
Cells; 2023 Mar; 12(6):. PubMed ID: 36980267
[TBL] [Abstract][Full Text] [Related]
6. Stem cell-based therapy for human diseases.
Hoang DM; Pham PT; Bach TQ; Ngo ATL; Nguyen QT; Phan TTK; Nguyen GH; Le PTT; Hoang VT; Forsyth NR; Heke M; Nguyen LT
Signal Transduct Target Ther; 2022 Aug; 7(1):272. PubMed ID: 35933430
[TBL] [Abstract][Full Text] [Related]
7. Role and Clinical Utility of Cancer/Testis Antigens in Head and Neck Squamous Cell Carcinoma.
Wu SC; Münger K
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830845
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic vs. autologous mesenchymal stem/stromal cells in their medication practice.
Li C; Zhao H; Cheng L; Wang B
Cell Biosci; 2021 Nov; 11(1):187. PubMed ID: 34727974
[TBL] [Abstract][Full Text] [Related]
9. mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients.
Bidram M; Zhao Y; Shebardina NG; Baldin AV; Bazhin AV; Ganjalikhany MR; Zamyatnin AA; Ganjalikhani-Hakemi M
Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696168
[TBL] [Abstract][Full Text] [Related]
10. Comment on: Endogenous retroviruses expressed in human tumours cannot be used as targets for anti-tumour vaccines.
Bermejo AV; Nielsen KN; Holst PJ
Transl Oncol; 2021 May; 14(5):101040. PubMed ID: 33810828
[No Abstract] [Full Text] [Related]
11. The expression, modulation and use of cancer-testis antigens as potential biomarkers for cancer immunotherapy.
Li XF; Ren P; Shen WZ; Jin X; Zhang J
Am J Transl Res; 2020; 12(11):7002-7019. PubMed ID: 33312347
[TBL] [Abstract][Full Text] [Related]
12. Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer.
Mediratta K; El-Sahli S; D'Costa V; Wang L
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33256070
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal stem/stromal cells: Developmental origin, tumorigenesis and translational cancer therapeutics.
Li C; Zhao H; Wang B
Transl Oncol; 2021 Jan; 14(1):100948. PubMed ID: 33190044
[TBL] [Abstract][Full Text] [Related]
14. Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions.
Caraccio C; Krishna S; Phillips DJ; Schürch CM
Front Immunol; 2020; 11():501. PubMed ID: 32391000
[TBL] [Abstract][Full Text] [Related]
15. NY-ESO-1 expression in solid tumors predicts prognosis: A systematic review and meta-analysis.
Wang H; Chen D; Wang R; Quan W; Xia D; Mei J; Xu J; Liu C
Medicine (Baltimore); 2019 Nov; 98(48):e17990. PubMed ID: 31770209
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem-like cells with increased expression of NY-ESO-1 initiate breast cancer metastasis.
Liu MY; Su H; Huang HL; Chen JQ
Oncol Lett; 2019 Oct; 18(4):3664-3672. PubMed ID: 31579408
[TBL] [Abstract][Full Text] [Related]
17. Expression dynamics of
Gordeeva O; Gordeev A; Khaydukov S
Oncotarget; 2019 May; 10(35):3248-3266. PubMed ID: 31143371
[TBL] [Abstract][Full Text] [Related]
18. ＜Editors' Choice＞ Meddling with meddlers: curbing regulatory T cells and augmenting antitumor immunity.
Kochin V; Nishikawa H
Nagoya J Med Sci; 2019 Feb; 81(1):1-18. PubMed ID: 30962651
[TBL] [Abstract][Full Text] [Related]
19. Cancer/testis antigens (CTAs) expression in resected lung cancer.
Jin S; Cao S; Li J; Meng Q; Wang C; Yao L; Lang Y; Cao J; Shen J; Pan B; Hu J; Yu Y
Onco Targets Ther; 2018; 11():4491-4499. PubMed ID: 30122941
[TBL] [Abstract][Full Text] [Related]
20. NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives.
Thomas R; Al-Khadairi G; Roelands J; Hendrickx W; Dermime S; Bedognetti D; Decock J
Front Immunol; 2018; 9():947. PubMed ID: 29770138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
